A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG s0316)

Sara H. Javid, Joseph M. Unger, Julie R. Gralow, Carol M. Moinpour, Antoinette J. Wozniak, J. Wendall Goodwin, Primo N Lara, Pamela A. Williams, Laura F. Hutchins, Carolyn C. Gotay, Kathy S. Albain

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Purpose. Patients older than 65 years are underrepresented in clinical trials. We conducted a prospective study (SWOG S0316) to determine physicianand patient-perceived barriers to breast cancer clinical trial enrollment for older patients. Methods. Eight geographically diverse SWOG institutions participated. The study assessed patients' and physicians' decisions to enroll in or decline clinical treatment trials, including demographics, trial availability, and eligibility. Patient and physician questionnaires elicited concerns related to treatment, medical status, age, family, and financial or transportation concerns. Results. A total of 1,079 patients were registered and eligible and 909 (84%) returned for follow-up. The major reason for nonaccrual was either trial unavailability or ineligibility (60%). Older patients were less likely to be eligible for trials (65% for age >65 years vs. 78% for age <65 years). If eligible,trialparticipationratesdidnotdiffersignificantlybyage (34%forage>65yearsvs.40%forage<65years).Patients >65yearsmoreoftenwereconcernedaboutsideeffects,had friends opposed to participation, or believed that participation would not benefit other generations. When trials were availableandpatientswereeligible,physiciansdiscussedtrial participation with 76% of patients <65 years versus 58% of patients >65 years of age. For patients >65 years, 11% of physicians indicated age as a reason they did not enroll a patient in a clinical trial. Conclusion. Trial unavailability or patient ineligibility were the major reasons for lack of enrollment in breast cancer clinical trials for patients of all ages in this prospective study. Older patients were less likely to be eligible for trials, but if eligible they participated at similar rates to younger patients.

Original languageEnglish (US)
Pages (from-to)1180-1190
Number of pages11
JournalOncologist
Volume17
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Decision Making
Clinical Trials
Breast Neoplasms
Physicians
Prospective Studies
Demography

Keywords

  • Breast cancer
  • Clinical trials
  • Elderly

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG s0316). / Javid, Sara H.; Unger, Joseph M.; Gralow, Julie R.; Moinpour, Carol M.; Wozniak, Antoinette J.; Wendall Goodwin, J.; Lara, Primo N; Williams, Pamela A.; Hutchins, Laura F.; Gotay, Carolyn C.; Albain, Kathy S.

In: Oncologist, Vol. 17, No. 9, 09.2012, p. 1180-1190.

Research output: Contribution to journalArticle

Javid, SH, Unger, JM, Gralow, JR, Moinpour, CM, Wozniak, AJ, Wendall Goodwin, J, Lara, PN, Williams, PA, Hutchins, LF, Gotay, CC & Albain, KS 2012, 'A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG s0316)', Oncologist, vol. 17, no. 9, pp. 1180-1190. https://doi.org/10.1634/theoncologist.2011-0384
Javid, Sara H. ; Unger, Joseph M. ; Gralow, Julie R. ; Moinpour, Carol M. ; Wozniak, Antoinette J. ; Wendall Goodwin, J. ; Lara, Primo N ; Williams, Pamela A. ; Hutchins, Laura F. ; Gotay, Carolyn C. ; Albain, Kathy S. / A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG s0316). In: Oncologist. 2012 ; Vol. 17, No. 9. pp. 1180-1190.
@article{b87ef6a762d3431fa4e2e7dd9b3632cf,
title = "A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG s0316)",
abstract = "Purpose. Patients older than 65 years are underrepresented in clinical trials. We conducted a prospective study (SWOG S0316) to determine physicianand patient-perceived barriers to breast cancer clinical trial enrollment for older patients. Methods. Eight geographically diverse SWOG institutions participated. The study assessed patients' and physicians' decisions to enroll in or decline clinical treatment trials, including demographics, trial availability, and eligibility. Patient and physician questionnaires elicited concerns related to treatment, medical status, age, family, and financial or transportation concerns. Results. A total of 1,079 patients were registered and eligible and 909 (84{\%}) returned for follow-up. The major reason for nonaccrual was either trial unavailability or ineligibility (60{\%}). Older patients were less likely to be eligible for trials (65{\%} for age >65 years vs. 78{\%} for age <65 years). If eligible,trialparticipationratesdidnotdiffersignificantlybyage (34{\%}forage>65yearsvs.40{\%}forage<65years).Patients >65yearsmoreoftenwereconcernedaboutsideeffects,had friends opposed to participation, or believed that participation would not benefit other generations. When trials were availableandpatientswereeligible,physiciansdiscussedtrial participation with 76{\%} of patients <65 years versus 58{\%} of patients >65 years of age. For patients >65 years, 11{\%} of physicians indicated age as a reason they did not enroll a patient in a clinical trial. Conclusion. Trial unavailability or patient ineligibility were the major reasons for lack of enrollment in breast cancer clinical trials for patients of all ages in this prospective study. Older patients were less likely to be eligible for trials, but if eligible they participated at similar rates to younger patients.",
keywords = "Breast cancer, Clinical trials, Elderly",
author = "Javid, {Sara H.} and Unger, {Joseph M.} and Gralow, {Julie R.} and Moinpour, {Carol M.} and Wozniak, {Antoinette J.} and {Wendall Goodwin}, J. and Lara, {Primo N} and Williams, {Pamela A.} and Hutchins, {Laura F.} and Gotay, {Carolyn C.} and Albain, {Kathy S.}",
year = "2012",
month = "9",
doi = "10.1634/theoncologist.2011-0384",
language = "English (US)",
volume = "17",
pages = "1180--1190",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "9",

}

TY - JOUR

T1 - A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG s0316)

AU - Javid, Sara H.

AU - Unger, Joseph M.

AU - Gralow, Julie R.

AU - Moinpour, Carol M.

AU - Wozniak, Antoinette J.

AU - Wendall Goodwin, J.

AU - Lara, Primo N

AU - Williams, Pamela A.

AU - Hutchins, Laura F.

AU - Gotay, Carolyn C.

AU - Albain, Kathy S.

PY - 2012/9

Y1 - 2012/9

N2 - Purpose. Patients older than 65 years are underrepresented in clinical trials. We conducted a prospective study (SWOG S0316) to determine physicianand patient-perceived barriers to breast cancer clinical trial enrollment for older patients. Methods. Eight geographically diverse SWOG institutions participated. The study assessed patients' and physicians' decisions to enroll in or decline clinical treatment trials, including demographics, trial availability, and eligibility. Patient and physician questionnaires elicited concerns related to treatment, medical status, age, family, and financial or transportation concerns. Results. A total of 1,079 patients were registered and eligible and 909 (84%) returned for follow-up. The major reason for nonaccrual was either trial unavailability or ineligibility (60%). Older patients were less likely to be eligible for trials (65% for age >65 years vs. 78% for age <65 years). If eligible,trialparticipationratesdidnotdiffersignificantlybyage (34%forage>65yearsvs.40%forage<65years).Patients >65yearsmoreoftenwereconcernedaboutsideeffects,had friends opposed to participation, or believed that participation would not benefit other generations. When trials were availableandpatientswereeligible,physiciansdiscussedtrial participation with 76% of patients <65 years versus 58% of patients >65 years of age. For patients >65 years, 11% of physicians indicated age as a reason they did not enroll a patient in a clinical trial. Conclusion. Trial unavailability or patient ineligibility were the major reasons for lack of enrollment in breast cancer clinical trials for patients of all ages in this prospective study. Older patients were less likely to be eligible for trials, but if eligible they participated at similar rates to younger patients.

AB - Purpose. Patients older than 65 years are underrepresented in clinical trials. We conducted a prospective study (SWOG S0316) to determine physicianand patient-perceived barriers to breast cancer clinical trial enrollment for older patients. Methods. Eight geographically diverse SWOG institutions participated. The study assessed patients' and physicians' decisions to enroll in or decline clinical treatment trials, including demographics, trial availability, and eligibility. Patient and physician questionnaires elicited concerns related to treatment, medical status, age, family, and financial or transportation concerns. Results. A total of 1,079 patients were registered and eligible and 909 (84%) returned for follow-up. The major reason for nonaccrual was either trial unavailability or ineligibility (60%). Older patients were less likely to be eligible for trials (65% for age >65 years vs. 78% for age <65 years). If eligible,trialparticipationratesdidnotdiffersignificantlybyage (34%forage>65yearsvs.40%forage<65years).Patients >65yearsmoreoftenwereconcernedaboutsideeffects,had friends opposed to participation, or believed that participation would not benefit other generations. When trials were availableandpatientswereeligible,physiciansdiscussedtrial participation with 76% of patients <65 years versus 58% of patients >65 years of age. For patients >65 years, 11% of physicians indicated age as a reason they did not enroll a patient in a clinical trial. Conclusion. Trial unavailability or patient ineligibility were the major reasons for lack of enrollment in breast cancer clinical trials for patients of all ages in this prospective study. Older patients were less likely to be eligible for trials, but if eligible they participated at similar rates to younger patients.

KW - Breast cancer

KW - Clinical trials

KW - Elderly

UR - http://www.scopus.com/inward/record.url?scp=84866541186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866541186&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2011-0384

DO - 10.1634/theoncologist.2011-0384

M3 - Article

C2 - 22723506

AN - SCOPUS:84866541186

VL - 17

SP - 1180

EP - 1190

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 9

ER -